Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma

Published:2022-07-01 Issue:3 Volume:28 Page:575-579
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Iwamoto Hideki^ORCID,Shimose Shigeo,Niizeki Takashi,Koga Hironori,Torimura Takuji,

Funder

Takeda Science Foundation

The Shinnihon Foundation of Advanced Medical Treatment Research

The Kurume University Branding Project

Yasuda Medical foundation

JSPS KAKENHI

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://e-cmh.org/upload/pdf/cmh-2022-0047.pdf

Reference7 articles.

1. IMbrave150: A randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma.

2. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

3. Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

4. Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice

5. Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma;iScience;2024-02

2. Predictors of Survival in Patients With Hepatocellular Cancer Receiving Atezolizumab and Bevacizumab;American Journal of Clinical Oncology;2023-12-04

3. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity;Clinical and Molecular Hepatology;2023-07-01

4. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective;Clinical and Molecular Hepatology;2023-04-01

5. A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-01-14